David P. Tusa - May 17, 2022 Form 4 Insider Report for SHARPS COMPLIANCE CORP (SMED)

Role
Former CEO and President
Signature
Diana Diaz, on behalf of Reporting Person
Stock symbol
SMED
Transactions as of
May 17, 2022
Transactions value $
$83,695
Form type
4
Date filed
5/18/2022, 03:55 PM
Previous filing
Aug 26, 2021
Next filing
May 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMED Common Stock Options Exercise $95K +25K +28.38% $3.80 113K May 17, 2022 Direct F1
transaction SMED Common Stock Sale -$106K -25K -22.11% $4.25 88.1K May 17, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMED Sharps Compliance 2010 Stock Plan Options Options Exercise $95K +25K +8.89% $3.80 306K May 17, 2022 Common Stock 25K $3.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cashless exercise and immediate sale through a broker of a stock award granted on February 13, 2019. All shares were issued under the Sharps Compliance Corp. 2010 Stock Plan and were scheduled to expire on February 13, 2026.
F2 This represents the weighted average sale of the 25,000 shares. Shares were sold between a range of $4.25 and $4.28.